SecurePortIV®: The cyanoacrylate adhesive providing a new gold standard for all vascular access care

Around two billion peripheral intravenous catheters are inserted each year globally. However, a large percentage of these lead to complications, such as infections or becoming dislodged, requiring replacement in order […]

Read More…

The heart of the matter: Clinical electrophysiology and beyond

Arrythmia – abnormal heart rhythm – can be life-limiting and even life-threatening. In this interview, Research Outreach talks to Professor Benjamin J Scherlag of the University of Oklahoma, USA, about […]

Read More…

Trypan blue venography: Evaluation and treatment of glaucoma

Glaucoma is linked to a build up of pressure in the eye as a result of impaired aqueous humour fluid outflow. However, there are limited options to evaluate aqueous outflow […]

Read More…

Exploring a novel approach to lung cancer treatment

Lung cancer, just like other types of cancer, is mostly treatable when diagnosed in the earliest stages. Treatments mainly include chemotherapy and surgeries such as sublobar resection and lobectomy. The […]

Read More…

When control is lost: Studying the interactions of ATP and acetylcholine in the urinary bladder

The inner lining of the bladder, known as the urothelium, not only serves as a passive barrier but also triggers the reflex controlling urination (the micturition reflex). The neurotransmitter ATP […]

Read More…

Heart valve disease: Improving patient care

The prevalence of heart valve disease is rising as life expectancy continues to increase. The management of heart valve disease is complex and several limitations in current clinic practice exist, […]

Read More…

Strengthening the case for goal directed fluid therapy

Intravenous (IV) fluids are critical for maintaining hydration and blood circulation during major abdominal surgery. The right amount of fluids can help prevent complications and speed up postoperative recovery, but […]

Read More…

Local drug delivery to prosthetic vascular grafts: Preventing failure of prosthetic grafts in haemodialysis patients

Dr Ronald J. Shebuski, President and CEO of Cylerus, Inc., wants to revolutionise the way vascular grafts work. His company, Cylerus, has an innovative way to deliver an antiproliferative drug, sirolimus, […]

Read More…

Guinea pig as a model to study the carotid body-mediated chronic intermittent hypoxia effects

The ability to sense and respond to changes in oxygen is essential for survival. Dr Ángela Gómez-Niño and Dr Asuncion Rocher along with their research team at Valladolid University aim […]

Read More…